Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Unknown 25 enrolled Herbert Irving Comprehensive Cancer Center

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have advanced soft tissue sarcoma.

Timeline

Start: 1998-09
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Temozolomide	Small molecule	—	Oral

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

Summary

Timeline

Drugs

Indications